Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
WHEN her father's lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly US$3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.
Ms Yin, like many families in...